Operating Profit 更改
Adcock Ingram Holdings ZAR 541.49M 52.55M 2023-06
Celltrion KRW 23.93B 8.77B 2024-03
Cspc Pharmaceutical CNY 1.79B 119.01M 2023-12
Dianthus Therapeutics USD -17844000 4.89M 2024-03
Ecofibre AUD -3356000 20.27M 2023-06
Eli Lilly USD 2.74B 347.8M 2024-03
Kangmei Pharma CNY -60459095.5 38.71M 2024-03
Knight Therapeutics CAD 2.66M 11.7M 2024-03
Laboratorios Farma EUR 19.28M 115.5M 2024-03
Malin Corporation EUR -2200000 800K 2023-06
Medical Developments International AUD -11427000 4.13M 2023-06
Neuren Pharmaceuticals AUD 48.83M 41.89M 2023-06
Organigram Holdings CAD -14977000 952K 2024-03
Pacira USD 15.11M 18.05M 2024-03
Perrigo USD -10900000 1.5M 2024-03
Pharma Mar EUR -4330000 788K 2024-03
Probiotec AUD 8.03M 492.24K 2023-06
Qiagen NV USD 98.24M 12.37M 2024-03
Sartorius EUR 122.3M 2.3M 2024-03
Sino Biopharmaceutical CNY 3.75B 797.83M 2023-06
Supernus Pharmaceuticals USD -4248000 3.25M 2024-03
Tilray USD -33371000 8.39M 2024-02
Zz Pientze Pharmaceu 1.04B 113.61M 2023-09



Xeris Pharmaceuticals 营业利润 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.